These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 12650234)

  • 41. Detection and diagnosis of malingering in electrical injury.
    Bianchini K; Love JM; Greve KW; Adams D
    Arch Clin Neuropsychol; 2005 May; 20(3):365-73. PubMed ID: 15797172
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Classification accuracy of MMPI-2 validity scales in the detection of pain-related malingering: a known-groups study.
    Bianchini KJ; Etherton JL; Greve KW; Heinly MT; Meyers JE
    Assessment; 2008 Dec; 15(4):435-49. PubMed ID: 18539782
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of poor effort on self-reported symptoms and neurocognitive test performance following mild traumatic brain injury.
    Lange RT; Iverson GL; Brooks BL; Rennison VL
    J Clin Exp Neuropsychol; 2010 Nov; 32(9):961-72. PubMed ID: 20437284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Symptom validity testing: a critical review.
    Bianchini KJ; Mathias CW; Greve KW
    Clin Neuropsychol; 2001 Feb; 15(1):19-45. PubMed ID: 11778576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The validity of the M test in a residential forensic facility.
    Hankins GC; Barnard GW; Robbins L
    Bull Am Acad Psychiatry Law; 1993; 21(1):111-21. PubMed ID: 8477102
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Embedded symptom validity tests and overall neuropsychological test performance.
    Meyers JE; Volbrecht M; Axelrod BN; Reinsch-Boothby L
    Arch Clin Neuropsychol; 2011 Feb; 26(1):8-15. PubMed ID: 21242283
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of somatoform symptomatology on credibility of cognitive performance.
    Boone KB; Lu PH
    Clin Neuropsychol; 1999 Nov; 13(4):414-9. PubMed ID: 10806453
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improvements in the M test as a screening measure for malingering.
    Rogers R; Bagby M; Gillis JR
    Bull Am Acad Psychiatry Law; 1992; 20(1):101-4. PubMed ID: 1576371
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment instruments measuring malingering used with individuals who have mental retardation: potential problems and issues.
    Hurley KE; Deal WP
    Ment Retard; 2006 Apr; 44(2):112-9. PubMed ID: 16689611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Malingering in toxic exposure: classification accuracy of reliable digit span and WAIS-III Digit Span scaled scores.
    Greve KW; Springer S; Bianchini KJ; Black FW; Heinly MT; Love JM; Swift DA; Ciota MA
    Assessment; 2007 Mar; 14(1):12-21. PubMed ID: 17314176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Known-groups cross-validation of the letter memory test in a compensation-seeking mixed neurologic sample.
    Vagnini VL; Sollman MJ; Berry DT; Granacher RP; Clark JA; Burton R; O'Brien M; Bacon E; Saier J
    Clin Neuropsychol; 2006 Jun; 20(2):289-304. PubMed ID: 16690548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Probable malingering and performance on the test of variables of attention.
    Henry GK
    Clin Neuropsychol; 2005 Feb; 19(1):121-9. PubMed ID: 15814483
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The value of the ophthalmological independent medical examination: analysis of 344 cases.
    Schutz JS; Mavrakanas NA
    Br J Ophthalmol; 2009 Oct; 93(10):1371-5. PubMed ID: 19570769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. American Academy of Clinical Neuropsychology Consensus Conference Statement on the neuropsychological assessment of effort, response bias, and malingering.
    Heilbronner RL; Sweet JJ; Morgan JE; Larrabee GJ; Millis SR;
    Clin Neuropsychol; 2009 Sep; 23(7):1093-129. PubMed ID: 19735055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The postconcussion syndrome and the sequelae of mild head injury.
    Evans RW
    Neurol Clin; 1992 Nov; 10(4):815-47. PubMed ID: 1435659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Test of Memory Malingering (TOMM) scores are not affected by chronic pain or depression in patients with fibromyalgia.
    Iverson GL; Le Page J; Koehler BE; Shojania K; Badii M
    Clin Neuropsychol; 2007 May; 21(3):532-46. PubMed ID: 17455036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Malingering on the social security disability consultative exam: predictors and base rates.
    Chafetz MD
    Clin Neuropsychol; 2008 May; 22(3):529-46. PubMed ID: 17853151
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exaggerated Functional Impairment due to Malingered Neurocognitive Dysfunction Following Mild Traumatic Brain Injury.
    Elias DA; MacLaren VV; Brien EK; Metcalfe AWS
    Arch Clin Neuropsychol; 2019 Jul; 34(5):648-656. PubMed ID: 30462149
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Test of Memory Malingering Performance is unaffected by laboratory-induced pain: implications for clinical use.
    Etherton JL; Bianchini KJ; Greve KW; Ciota MA
    Arch Clin Neuropsychol; 2005 May; 20(3):375-84. PubMed ID: 15797173
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Malingering and uncooperativeness in psychiatric and psychological assessment: prevalence and effects in a German sample of claimants.
    Stevens A; Friedel E; Mehren G; Merten T
    Psychiatry Res; 2008 Jan; 157(1-3):191-200. PubMed ID: 17977603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.